"Elbrus the Capital" invested fund "Elbrus Kapital" omnikanalny advance of pharmaceutical brands of BREFFI

The Elbrus Capital Fund III fund got a large minority share in BREFFI, the leading Russian companies, engaged in omnikanalny marketing of pharmaceutical brands. The amount of transaction made 750 million rubles Bólshaya part of means will be aimed at development companies, scaling the current businesses and creation of new digital products in the field of health care. From the moment of BREFFI basis the main focus of companies was advance to Russian Federation the branded medicines, mainly through medical community. At the moment at BREFFI more than 100 clients, the majority from which –...